Flibanserin Raw Powder
China Steroid Raws/ Sarms/ Peptides sell on line. If you want to know more details, please contact Jason on: Email: email@example.com WhatsApp: +8618042849221
1. Product Introduction
CAS No.: 167933-07-5
Molecular formula: C20H21F3N4O
Molecular weight: 390.4
Appearance: White powder
Grade: Pharmaceutical grade
Usage: Adrug being studied as a non-hormonal treatment for pre-menopausal women with hypoactive sexual desire disorder (HSDD)
2. Product description:
Flibanserin, the new drug, is the world's first drug to help women improve low libido, reducing the 5-hydroxytryptamine that inhibits libido and boosting libido-stimulating dopamine levels. The drug has been approved by the US Food and Drug Administration (FDA).
This product can directly affect the female brain control pleasure area, thus restoring the female gradually declining sexual desire. By regulating the human body system that stimulates sexual desire, fluribanserine helps restore the balance between libido inhibition and excitement, and ultimately leads to healthy sexual desire expression. The effect of this drug is not immediate and takes several weeks before it can be effective. Female Viagra also had side effects, with one in eight women experiencing dizziness, fatigue and sleepiness.
Fluribanserine is similar to antidepressants in that it affects the brain's secretion of emotional and desire-related chemicals. In fact, it has been used as a cure for depression before it becomes a supportive drug.
Unlike the "Viagra" principle, fluorine is regulated by chemicals in the female brain. In addition, Viagra is effective in most men, and fluribanserine only works in women with significantly reduced libido. If the drug user has no interest in a person, it can not be awakened by fluorine. "Fluribanserine doesn't cause excessive sexual desire," says Anita Clayton, a consultant at Drug Research and Development. However, it takes time for this medicine to work, and fluorine is required for women to take it every day.
3. Flibanserin COA:
|Loss on Drying||≤1.0%||0.5%|
|Conclusion:The product meets In-house specifications.|
4. Avanafil Application:
A new drug designed to boost sexual desire in women is controversial for some and eagerly awaited by others, but it's hit a potentially serious snag. The drug didn't boost women's desire any more than a placebo in two clinical trials. The Food and Drug Administration posted the clinical trial results on its website today in advance of a committee meeting on Friday, when a panel of experts will vote whether or not to recommend approval of the drug called flibanserin. (The FDA usually follows the recommendations of its expert panels. ) Although there was a slight increase in the number of sexually satisfying events flibanserin users had each month, the FDA staff who reviewed the results said the so-called response rate isn't "particularly compelling.
"HSDD is the most commonly reported form of female sexual dysfunction. HSDD is defined as a persistent or recurrent deficiency or absence of sexual fantasies and desire for sexual activity that causes marked distress or interpersonal difficulty, and which is not better accounted for by a medical, substance-related, psychiatric (e. G., depression) or other sexual condition. The cause of HSDD is believed to involve a multitude of social, psychological and biological factors and may be attributed to a complex interplay of these factors.
5. Related Products:
Sex Enchancer Powder